Healthcare company GlaxoSmithKline (GSK) has said it is to invest £25m in expanding its operations in Montrose.

Some £2.7m had already been set aside by Angus Council for the project, but in addition to this, Scottish Enterprise has now also awarded the local authority £1.5m to improve access into the GSK site and its surrounding area.

As part of the multi-million pound investment, the firm will deliver new state-of-the-art facilities and equipment to bring production of the ingredients for four new pharmaceutical products. A further 25 GSK jobs will be created with the expansion, while an additional 50 contractors will be employed during the construction phase.

-- Advertisement --

Welcoming the news, Finance Secretary John Swinney said: "GSK's investment is testament to the skill of the Scottish workforce and illustrates the confidence international companies have in Scotland as a country to invest in.

"Montrose has the infrastructure, experience and skills to deliver success for GSK and the company's commitment to Scotland is further positive news for financial enterprise and the wider Scottish economy.

"We acknowledge the support of both Angus Council and Scottish Enterprise in developing the proposals to support the infrastructure of the surrounding South Montrose area.

"The Scottish Government, Scottish Development International and Scottish Enterprise will continue to do all we can to make Scotland an attractive location for inward investment."

Roger Connor, President, Global Manufacturing and Supply for GSK, added: "Our teams in Montrose and Irvine are world class and have worked hard to bring new facilities to the two sites. This investment shows how highly we value our teams in Scotland."

(JP/IT)